The Patent Finder

Pharming Intellectual Property B.V.

Also on record
Records under this name other than the patents Pharming Intellectual Property B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to Pharming Intellectual Property B.V.

PatentTitleStatus Expires Confidence
US 7,067,713C1 Inhibitor Produced in the Milk of Transgenic Non--Human Mammals
Term ended
Term ended Oct 7, 2026 · High confidence
Term endedTerm ended Oct 7, 2026High confidence
US RE43,691C1 Inhibitor with Short Half-Life Transient Treatment
Term ended
Term ended May 14, 2024 · Low confidence
Term endedTerm ended May 14, 2024Low confidence
US 6,713,662Production of collagen in the milk of transgenic mammals
Formerly held
Term ended
Term ended Jun 27, 2022 · From the USPTO record
Term endedTerm ended Jun 27, 2022From the USPTO record
US 9,962,431Treatment of bleeding with low half-life fibrinogen
Formerly held
Lapsed on the fee record
Ended May 8, 2022 · From the USPTO record
Lapsed on the fee recordEnded May 8, 2022From the USPTO record
US 8,557,773Treatment of bleeding with low half-life fibrinogen
Formerly held
Lapsed on the fee record
Ended Oct 15, 2021 · From the USPTO record
Lapsed on the fee recordEnded Oct 15, 2021From the USPTO record
US 7,045,677Fusion Proteins Incorporating Lysozyme
Term ended
Term ended Feb 22, 2021 · Medium confidence
Term endedTerm ended Feb 22, 2021Medium confidence
US 9,546,381Use of Anticoagulants in the Production of Recombinant Proteins in the Milk of Transgenic Animals
Lapsed on the fee record
Ended Jan 17, 2021 · High confidence
Lapsed on the fee recordEnded Jan 17, 2021High confidence
US 6,740,736Purification of fibrinogen from milk by use of cation exchange chromatography
Formerly held
Term ended
Term ended Mar 12, 2020 · From the USPTO record
Term endedTerm ended Mar 12, 2020From the USPTO record
US 7,655,226Treatment of Pompe's Disease
Formerly held
Term ended
Ended no later than Dec 16, 2019 · Low confidence
Term endedEnded no later than Dec 16, 2019Low confidence
US 9,212,215Treatment of bleeding with low half-life fibrinogen
Formerly held
Lapsed on the fee record
Ended Dec 15, 2019 · From the USPTO record
Lapsed on the fee recordEnded Dec 15, 2019From the USPTO record
10 of 50 patents shown.
Pro members see all 50.
Pro members: see all 50 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited